Consequently, impaired NET clearance is a key pathogenic mechanism in SLE, associated with lower complement levels (C3, C4) and higher susceptibility to glomerulonephritis in patients with elevated NET levels [41,42]. This evidence concerns the gene C3 and systemic lupus erythematosus.